Sage Therapeutics
SAGE
#7026
Rank
โ‚ฌ0.46 B
Marketcap
7,39ย โ‚ฌ
Share price
0.00%
Change (1 day)
-2.87%
Change (1 year)

Revenue for Sage Therapeutics (SAGE)

Revenue in 2025 (TTM): โ‚ฌ62.83 Million

According to Sage Therapeutics 's latest financial reports the company's current revenue (TTM ) is โ‚ฌ59.97 Million. In 2024 the company made a revenue of โ‚ฌ39.63 Million a decrease over the revenue in the year 2023 that were of โ‚ฌ78.2 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Sage Therapeutics from 2013 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚ฌ62.83 M58.54%
2024 โ‚ฌ39.63 M-49.32%
2023 โ‚ฌ78.2 M991.35%
2022 โ‚ฌ7.16 M28.66%
2021 โ‚ฌ5.56 M-99.39%
2020 โ‚ฌ0.90 B14675.38%
2019 โ‚ฌ6.13 M-92.23%
2018 โ‚ฌ78.91 M
2017 N/A
2016 N/A
2015 N/A
2014 N/A
2013 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Regulus Therapeutics
RGLS
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Eagle Pharmaceuticals
EGRX
โ‚ฌ0.21 B 265.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Horizon Therapeutics
HZNP
โ‚ฌ3.10 B 5,075.98%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Intercept Pharmaceuticals
ICPT
โ‚ฌ0.27 B 351.19%๐Ÿ‡บ๐Ÿ‡ธ USA